Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,289,000 | 4,286,000 | 4,309,000 | 2,745,000 | 1,372,000 |
| Depreciation Amortization | 2,039,000 | 12,862,000 | 6,284,000 | 4,205,000 | 2,074,000 |
| Income taxes - deferred | -28,000 | -1,449,000 | -682,000 | -405,000 | -389,000 |
| Accounts receivable | -1,479,000 | 207,000 | -180,000 | -524,000 | -702,000 |
| Accounts payable and accrued liabilities | -696,000 | 177,000 | -1,070,000 | -1,337,000 | 362,000 |
| Other Working Capital | -2,563,000 | -2,845,000 | -2,385,000 | -3,188,000 | 214,000 |
| Other Operating Activity | 3,073,000 | 5,568,000 | 5,482,000 | 4,815,000 | 1,109,000 |
| Operating Cash Flow | $1,635,000 | $18,806,000 | $11,758,000 | $6,311,000 | $4,040,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -235,000 | -974,000 | -683,000 | -434,000 | -193,000 |
| Net Acquisitions | -538,000 | -20,517,000 | -18,725,000 | -10,232,000 | -9,389,000 |
| Purchase Of Investment | N/A | -73,000 | -46,000 | -22,000 | -6,000 |
| Sale Of Investment | N/A | 555,000 | 516,000 | 9,000 | 6,000 |
| Other Investing Activity | 38,000 | 189,000 | -8,000 | -11,000 | -6,000 |
| Investing Cash Flow | $-735,000 | $-20,820,000 | $-18,946,000 | $-10,690,000 | $-9,588,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,593,000 | 5,008,000 | 5,008,000 | 5,008,000 | 5,008,000 |
| Debt Issued | 3,994,000 | 16,963,000 | 14,963,000 | 14,963,000 | 14,963,000 |
| Debt Repayment | -3,026,000 | -9,613,000 | -3,851,000 | -3,448,000 | -103,000 |
| Common Stock Issued | N/A | 214,000 | 204,000 | 137,000 | 127,000 |
| Common Stock Repurchased | -961,000 | -1,708,000 | -1,350,000 | -1,333,000 | -1,324,000 |
| Dividend Paid | -2,925,000 | -11,025,000 | -8,273,000 | -5,522,000 | -2,772,000 |
| Other Financing Activity | 67,000 | -5,050,000 | -5,051,000 | -5,083,000 | -5,080,000 |
| Financing Cash Flow | $-1,258,000 | $-5,211,000 | $1,650,000 | $4,722,000 | $10,819,000 |
| Exchange Rate Effect | 9,000 | -65,000 | -19,000 | -27,000 | -18,000 |
| Beginning Cash Position | 5,524,000 | 12,814,000 | 12,814,000 | 12,814,000 | 12,814,000 |
| End Cash Position | 5,175,000 | 5,524,000 | 7,257,000 | 13,130,000 | 18,067,000 |
| Net Cash Flow | $-349,000 | $-7,290,000 | $-5,557,000 | $316,000 | $5,253,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,635,000 | 18,806,000 | 11,758,000 | 6,311,000 | 4,040,000 |
| Capital Expenditure | -235,000 | -974,000 | -683,000 | -434,000 | -193,000 |
| Free Cash Flow | 1,400,000 | 17,832,000 | 11,075,000 | 5,877,000 | 3,847,000 |